Ondansetron compared with metoclopramide for hyperemesis gravidarum: A randomized controlled trial

Obstetrics and Gynecology

Volumn 123, Issue 6, 2014, Pages 1272-1279

  Abas, Mohamed Norazam ^a   Tan, Peng Chiong ^a   Azmi, Noor ^a   Omar, Siti Zawiah ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

METOCLOPRAMIDE; ONDANSETRON;

10 POINT VISUAL NUMERIC RATING SCALE; ADULT; ARTICLE; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HEART PALPITATION; HOSPITALIZATION; HUMAN; HYPEREMESIS GRAVIDARUM; LENGTH OF STAY; MAJOR CLINICAL STUDY; NAUSEA; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RISK BENEFIT ANALYSIS; SOMNOLENCE; TREATMENT DURATION; VOMITING; WELLBEING; XEROSTOMIA;

ADULT; ANTIEMETICS; FEMALE; HUMANS; HYPEREMESIS GRAVIDARUM; METOCLOPRAMIDE; ONDANSETRON; PREGNANCY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84901612418     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000000242     Document Type: Article

References (29)

1. Bottomley C, Bourne T. Management strategies for hyperemesis. Best Pract Res Clin Obstet Gynaecol 2009;23:549-64.
2. Tan PC, Omar SZ. Contemporary approaches to hyperemesis during pregnancy. Curr Opin Obstet Gynecol 2011;23:87-93.
3. Nausea and vomiting of pregnancy. ACOG Practice Bulletin No.
4. American College of Obstetricians and Gynecologists. Obstet Gynecol 2004;103:803-14.
5. Tan PC, Khine PP, Vallikkannu N, Omar SZ. Promethazine compared with metoclopramide for hyperemesis gravidarum: a randomized controlled trial. Obstet Gynecol 2010;115:975-81.
6. Raymond SH. A survey of prescribing for the management of nausea and vomiting in pregnancy in Australasia. Aust N Z J Obstet Gynaecol 2013;53:358-62.
7. Matok I, Gorodischer R, Koren G, Sheiner E, Wiznitzer A, Levy A. The safety of metoclopramide use in the first trimester of pregnancy. N Engl J Med 2009;360:2528-35.
8. Pasternak B, Svanstrom H, Molgaard-Nielsen D, Melbye M, Hviid A. Metoclopramide in pregnancy and risk of major congenital malformations and fetal death. JAMA 2013;310:1601-11.
9. Guikontes E, Spantideas A, Diakakis J. Ondansetron and hyperemesis gravidarum. Lancet 1992;340:1223.
10. Sullivan CA, Johnson CA, Roach H, Martin RW, Stewart DK, Morrison JC. A pilot study of intravenous ondansetron for hyperemesis gravidarum. Am J Obstet Gynecol 1996;174:1565-8.
11. Niebyl JR. Clinical practice. Nausea and vomiting in pregnancy. N Engl J Med 2010;363:1544-50.
12. Einarson A,Maltepe C, Navioz Y, Kennedy D, TanMP, Koren G. The safety of ondansetron for nausea and vomiting of pregnancy: a prospective comparative study. BJOG 2004;111:940-3.
13. Tucker ML, Jackson MR, Scales MD, Spurling NW, Tweats DJ, Capel-Edwards K. Ondansetron: pre-clinical safety evaluation. Eur J Cancer Clin Oncol 1989;25(SUPPL 1):S79-93.
14. Pasternak B, Svanstrom H, Hviid A. Ondansetron in pregnancy and risk of adverse fetal outcomes. N Engl JMed 2013;368:814-23.
15. Cunningham RS. 5-HT3-receptor antagonists: a review of pharmacology and clinical efficacy. Oncol Nurs Forum 1997;24 (SUPPL 7):33-40.
16. Tramer MR, Reynolds DJ, Stoner NS, Moore RA, McQuay HJ. Efficacy of 5-HT3 receptor antagonists in radiotherapy-induced nausea and vomiting: a quantitative systematic review. Eur J Cancer 1998;34:1836-44.
17. Wu SJ, Xiong XZ, Cheng TY, Lin YX, Cheng NS. Efficacy of ondansetron vs. metoclopramide in prophylaxis of postoperative nausea and vomiting after laparoscopic cholecystectomy: a systematic review and meta-analysis. Hepatogastroenterology 2012;59:2064-74.
18. Domino KB, Anderson EA, Polissar NL, Posner KL. Comparative efficacy and safety of ondansetron, droperidol, and metoclopramide for preventing postoperative nausea and vomiting: a meta-analysis. Anesth Analg 1999;88:1370-9.
19. Figueredo ED, Canosa LG. Ondansetron in the prophylaxis of postoperative vomiting: a meta-analysis. J Clin Anesth 1998;10: 211-21.
20. Tan PC, Yow CM, Omar SZ. A placebo-controlled trial of oral pyridoxine in hyperemesis gravidarum. Gynecol Obstet Invest 2009;67:151-7.
21. Tan PC, King AS, Omar SZ. Screening for urinary tract infection in women with hyperemesis gravidarum. J Obstet Gynaecol Res 2012;38:145-53.
22. Kashifard M, Basirat Z, Golsorkhtabar-Amiri M, Moghaddamnia A. Ondansetrone or metoclopromide? Which is more effective in severe nausea and vomiting of pregnancy? A randomized trial double-blind study. Clin Exp Obstet Gynecol 2013;40:127-30.
23. Klauser CK, Fox NS, Istwan N, Rhea D, Rebarber A, Desch C, et al. Treatment of severe nausea and vomiting of pregnancy with subcutaneous medications. Am J Perinatol 2011;28:715-21.
24. Pan PH, Moore CH. Comparing the efficacy of prophylactic metoclopramide, ondansetron, and placebo in cesarean section patients given epidural anesthesia. J Clin Anesth 2001;13: 430-5.
25. AnderkaM,Mitchell AA, Louik C,Werler MM, Hernandez-Diaz S, Rasmussen SA. Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects. Birth defects research Part A, Clin Mol Teratology 2012;94:22-30.
26. Jewell D, Young G. Interventions for nausea and vomiting in early pregnancy. The Cochrane Database of Systematic Reviews 2003, Issue 9. Art. No.: CD000145. DOI: 10.1002/14651858. CD000145.
27. Tan PC, Jacob R, Quek KF, Omar SZ. Readmission risk and metabolic, biochemical, haematological and clinical indicators of severity in hyperemesis gravidarum. Aust N Z J Obstet Gynaecol 2006;46:446-50.
28. Goodwin TM, Montoro M, Mestman JH. Transient hyperthyroidism and hyperemesis gravidarum: clinical aspects. Am J Obstet Gynecol 1992;167:648-52.
29. Bashiri A, Neumann L, Maymon E, Katz M. Hyperemesis gravidarum: epidemiologic features, complications and outcome. Eur J Obstet Gynecol Reprod Biol 1995;63:135-8.